REVERSIBILITY OF PULMONARY HYPERTENSION

被引：0
|
作者：
不详
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 1969年 / 1卷 / 5638期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：201 / +
页数：1
相关论文
共 50 条
  • [41] Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease
    Egito, EST
    Aiello, VD
    Bosisio, IBJ
    Lichtenfels, AJ
    Horta, ALM
    Saldiva, PHN
    Capelozzi, VL
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (08) : 521 - 532
  • [42] REVERSIBILITY OF PRIMARY PULMONARY-HYPERTENSION DURING 6 YEARS OF TREATMENT WITH ORAL DIAZOXIDE
    HALL, DR
    PETCH, MC
    BRITISH HEART JOURNAL, 1987, 58 (04): : 420 - 420
  • [43] REVERSIBILITY OF PRIMARY PULMONARY-HYPERTENSION WITH VASODILATOR, ANTICOAGULANT AND NOCTURNAL OXYGEN-THERAPY
    KANEMOTO, N
    YAMAGUCHI, H
    SHIINA, Y
    GOTO, Y
    JAPANESE HEART JOURNAL, 1989, 30 (06): : 929 - 934
  • [44] Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease
    David M. Smadja
    Pascale Gaussem
    Laetitia Mauge
    Romaric Lacroix
    Sophie Gandrille
    Véronique Remones
    Séverine Peyrard
    Florence Sabatier
    Damien Bonnet
    Marilyne Lévy
    Pediatric Cardiology, 2010, 31 : 657 - 662
  • [45] Reversibility of pulmonary hypertension assessment as an expected standard of diagnosis and prognosis on cardiology ward in Poland
    Swierad, Marcin
    Zakliczynski, Michal
    Maruszewski, Marcin
    Zebik, Tadeusz
    Honisz, Grzegorz
    Chodor, Piotr
    Wojarski, Jacek
    Nadziakiewicz, Pawel
    Kucewicz, Ewa
    Przybylski, Roman
    Gasior, Mariusz
    Polonski, Lech
    Kalarus, Zbigniew
    Zembala, Marian
    KARDIOLOGIA POLSKA, 2009, 67 (01) : 106 - 109
  • [46] REVERSIBILITY OF PRIMARY PULMONARY-HYPERTENSION DURING 6 YEARS OF TREATMENT WITH ORAL DIAZOXIDE
    CHAN, NS
    MCLAY, J
    KENMURE, ACF
    BRITISH HEART JOURNAL, 1987, 57 (02): : 207 - 209
  • [47] Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
    Tavares-Silva, Marta
    Saraiva, Francisca
    Pinto, Roberto
    Amorim, Sandra
    Silva, Joao Carlos
    Leite-Moreira, Adelino F.
    Maciel, Maria Julia
    Lourenco, Andre P.
    ESC HEART FAILURE, 2021, 8 (02): : 908 - 917
  • [48] Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease
    Smadja, David M.
    Gaussem, Pascale
    Mauge, Laetitia
    Lacroix, Romaric
    Gandrille, Sophie
    Remones, Veronique
    Peyrard, Severine
    Sabatier, Florence
    Bonnet, Damien
    Levy, Marilyne
    PEDIATRIC CARDIOLOGY, 2010, 31 (05) : 657 - 662
  • [49] Reversibility of pulmonary hypertension in patients with heart failure is associated with mitral flow velocity changes
    Dini, FL
    Nuti, R
    Barsotti, L
    Micheli, G
    De Tommasi, SM
    EUROPEAN HEART JOURNAL, 2003, 24 : 401 - 401
  • [50] The Novel Use of Mechanical Circulatory Support to Demonstrate Pulmonary Hypertension Reversibility in Mitral Stenosis
    Sparks, A.
    Kawabori, M.
    Nordan, T.
    Hironaka, C.
    Zahn, Y.
    Chen, F.
    Couper, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S498 - S498
12345